Lipid-based Polyene Antifungal [EPC]

12943 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 2527
1 OFF LABEL USE 1204
2 PYREXIA 793
3 CONDITION AGGRAVATED 512
4 SEPSIS 506
5 FEBRILE NEUTROPENIA 503
6 PNEUMONIA 470
7 HYPOKALAEMIA 465
8 ACUTE KIDNEY INJURY 400
9 RENAL IMPAIRMENT 397
See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 15 0.6250
1 PANCREATIC CYSTADENOMA 9 0.4500
2 VENA CAVA INJURY 22 0.2750
3 CHOROIDITIS 67 0.2367
4 HEPATOSPLENIC CANDIDIASIS 25 0.2137
5 PERINEAL CYST 11 0.2037
6 DIAPHRAGMATIC INJURY 12 0.1935
7 PYELONEPHRITIS FUNGAL 8 0.1860
8 GEOTRICHUM INFECTION 30 0.1765
9 FUNGAL ENDOCARDITIS 34 0.1700
See all enriched reactions for Lipid-based Polyene Antifungal [EPC]